The Bergen 4-Day Treatment for panic disorder patients in a rural clinical setting: a long-term follow-up study.

IF 3.4 2区 医学 Q2 PSYCHIATRY BMC Psychiatry Pub Date : 2025-01-02 DOI:10.1186/s12888-024-06445-0
Thorstein Olsen Eide, Thorbjørn Olsen, Hans Hansen, Bjarne Hansen, Stian Solem, Kristen Hagen
{"title":"The Bergen 4-Day Treatment for panic disorder patients in a rural clinical setting: a long-term follow-up study.","authors":"Thorstein Olsen Eide, Thorbjørn Olsen, Hans Hansen, Bjarne Hansen, Stian Solem, Kristen Hagen","doi":"10.1186/s12888-024-06445-0","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The Bergen 4-Day Treatment (B4DT) is a concentrated cognitive behaviour therapy (CBT) approach that has shown promise in treating panic disorder (PD). However, the effectiveness of the B4DT, particularly regarding long-term outcomes in rural clinical settings, remains underexplored.</p><p><strong>Methods: </strong>A total of 58 patients were included using a naturalistic open-label trial design. Patients were assessed at 12-month follow-up. Measures included the Panic Disorder Severity Scale (PDSS), the Patient Health Questionnaire-9 (PHQ-9), and the Generalized Anxiety Disorder-7 scale (GAD-7).</p><p><strong>Results: </strong>The study revealed significant and lasting reductions in PD symptoms, with a high rate of remission maintained at 12-month follow-up (82.8%). Regarding the secondary outcomes, significant improvements in symptoms of depression and generalized anxiety were also shown.</p><p><strong>Conclusions: </strong>The B4DT represents a promising treatment approach for PD, demonstrating stable long-term outcomes in rural settings. This finding supports the potential of concentrated CBT formats in achieving sustained symptom improvement in patients with PD, warranting further investigation and broader implementation.</p><p><strong>Trial registration: </strong>The study was reviewed by the Regional Committee for Medical Research Ethics Northern Norway, REK North (REK Nord2021/273145).</p>","PeriodicalId":9029,"journal":{"name":"BMC Psychiatry","volume":"25 1","pages":"3"},"PeriodicalIF":3.4000,"publicationDate":"2025-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11697728/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Psychiatry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12888-024-06445-0","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The Bergen 4-Day Treatment (B4DT) is a concentrated cognitive behaviour therapy (CBT) approach that has shown promise in treating panic disorder (PD). However, the effectiveness of the B4DT, particularly regarding long-term outcomes in rural clinical settings, remains underexplored.

Methods: A total of 58 patients were included using a naturalistic open-label trial design. Patients were assessed at 12-month follow-up. Measures included the Panic Disorder Severity Scale (PDSS), the Patient Health Questionnaire-9 (PHQ-9), and the Generalized Anxiety Disorder-7 scale (GAD-7).

Results: The study revealed significant and lasting reductions in PD symptoms, with a high rate of remission maintained at 12-month follow-up (82.8%). Regarding the secondary outcomes, significant improvements in symptoms of depression and generalized anxiety were also shown.

Conclusions: The B4DT represents a promising treatment approach for PD, demonstrating stable long-term outcomes in rural settings. This finding supports the potential of concentrated CBT formats in achieving sustained symptom improvement in patients with PD, warranting further investigation and broader implementation.

Trial registration: The study was reviewed by the Regional Committee for Medical Research Ethics Northern Norway, REK North (REK Nord2021/273145).

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
卑尔根4天治疗恐慌症患者在农村临床设置:一个长期随访研究。
背景:卑尔根4天治疗(B4DT)是一种集中的认知行为治疗(CBT)方法,在治疗惊恐障碍(PD)方面显示出希望。然而,B4DT的有效性,特别是关于农村临床环境的长期结果,仍未得到充分探索。方法:采用自然开放标签试验设计,共纳入58例患者。在12个月的随访中对患者进行评估。测量方法包括惊恐障碍严重程度量表(PDSS)、患者健康问卷-9 (PHQ-9)和广泛性焦虑障碍-7量表(GAD-7)。结果:研究显示PD症状显著且持续减轻,在12个月的随访中保持了很高的缓解率(82.8%)。关于次要结局,抑郁症和广泛性焦虑症状也有显著改善。结论:B4DT代表了一种很有前途的PD治疗方法,在农村环境中显示出稳定的长期效果。这一发现支持了集中CBT形式在实现PD患者持续症状改善方面的潜力,值得进一步研究和更广泛的实施。试验注册:该研究由北挪威医学研究伦理区域委员会REK North (REK Nord2021/273145)审查。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
BMC Psychiatry
BMC Psychiatry 医学-精神病学
CiteScore
5.90
自引率
4.50%
发文量
716
审稿时长
3-6 weeks
期刊介绍: BMC Psychiatry is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of psychiatric disorders, as well as related molecular genetics, pathophysiology, and epidemiology.
期刊最新文献
Frailty-related vulnerability and immune cell profiles in younger adults with schizophrenia: an exploratory study. The association between spatiotemporal coupling of default mode network and behaviors is specifically modulated by peripheral inflammation in major depressive disorder. Neurocognitive function profiles in Chinese patients with melancholic vs. non-melancholic major depressive disorder. Clinical characteristics and predictive modelling of intentional self-poisoning with prescribed medications among Chinese adolescents: a five-year retrospective study. Impact of interventions addressing perinatal mental health on loneliness and/or satisfaction with social support: systematic review.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1